P. K. Manna

603 total citations
27 papers, 388 citations indexed

About

P. K. Manna is a scholar working on Pharmaceutical Science, Molecular Biology and Pharmacology. According to data from OpenAlex, P. K. Manna has authored 27 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmaceutical Science, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in P. K. Manna's work include Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Cancer therapeutics and mechanisms (3 papers). P. K. Manna is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Cancer therapeutics and mechanisms (3 papers). P. K. Manna collaborates with scholars based in India, Germany and United States. P. K. Manna's co-authors include Guru Mohanta, R. Manavalan, Utpal Jana, Amulya K. Panda, Vibhu Kanchan, Pratap C. Naha, Tulika Prasad, R. P. Singh, R Kalaiselvan and Veliah Chelladurai and has published in prestigious journals such as Physical Review Letters, Applied Physics Letters and International Journal of Pharmaceutics.

In The Last Decade

P. K. Manna

23 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. K. Manna India 8 111 78 76 58 56 27 388
Alessandra Lifsitch Viçosa Brazil 12 113 1.0× 54 0.7× 48 0.6× 86 1.5× 52 0.9× 28 426
Maria Betânia de Freitas Marques Brazil 11 76 0.7× 83 1.1× 49 0.6× 68 1.2× 58 1.0× 35 373
Flávia Almada do Carmo Brazil 15 159 1.4× 69 0.9× 76 1.0× 51 0.9× 86 1.5× 44 478
Brittany L. B. Nichols United States 7 165 1.5× 74 0.9× 78 1.0× 41 0.7× 64 1.1× 9 362
Shin-ichiro Kimura Japan 11 192 1.7× 56 0.7× 58 0.8× 73 1.3× 82 1.5× 29 432
Nagesh H. Aloorkar India 10 242 2.2× 55 0.7× 57 0.8× 39 0.7× 41 0.7× 28 402
Rampurna Prasad Gullapalli United States 7 130 1.2× 55 0.7× 78 1.0× 54 0.9× 53 0.9× 10 404
Mohammad F. Bayan Jordan 13 81 0.7× 41 0.5× 57 0.8× 57 1.0× 53 0.9× 23 328
Chandra Prakash Jain India 8 152 1.4× 44 0.6× 56 0.7× 60 1.0× 54 1.0× 18 496
Srinivas Ajjarapu United States 11 127 1.1× 49 0.6× 51 0.7× 51 0.9× 138 2.5× 13 364

Countries citing papers authored by P. K. Manna

Since Specialization
Citations

This map shows the geographic impact of P. K. Manna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. K. Manna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. K. Manna more than expected).

Fields of papers citing papers by P. K. Manna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. K. Manna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. K. Manna. The network helps show where P. K. Manna may publish in the future.

Co-authorship network of co-authors of P. K. Manna

This figure shows the co-authorship network connecting the top 25 collaborators of P. K. Manna. A scholar is included among the top collaborators of P. K. Manna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. K. Manna. P. K. Manna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bera, S. K., et al.. (2025). Thermoresponsive solid lipid nanoparticles and its potential for CNS tumor therapy. International Journal of Pharmaceutics. 681. 125819–125819.
2.
Manna, P. K., et al.. (2025). Ising Superconductivity in Bulk Layered Noncentrosymmetric 4 H NbSe 2 . Physical Review Letters. 135(21). 216002–216002.
3.
Manna, P. K., et al.. (2025). Lightweight 3d-element-rich high-entropy alloy superconductor with high critical field and current density. Physical Review Materials. 9(9). 1 indexed citations
4.
Maity, R., et al.. (2025). Amplifying therapeutic potential through optimization of bioavailability of poorly soluble flavonols via albumin-based nanoparticles. Drug Development and Industrial Pharmacy. 51(6). 534–545.
5.
Manna, P. K., et al.. (2024). Superconducting Properties of Layered Chalocogenides 1T$1T$‐RhSeTe. Advanced Quantum Technologies. 7(12). 2 indexed citations
6.
Manna, P. K., et al.. (2024). Superconductivity in breathing kagome-structured C14 Laves phase XOs2(X = Zr, Hf). Superconductor Science and Technology. 37(7). 75004–75004. 7 indexed citations
7.
Manna, P. K., et al.. (2024). Superconductivity with a high upper critical field in an equiatomic high-entropy alloy Sc–V–Ti–Hf–Nb. Applied Physics Letters. 124(19). 18 indexed citations
8.
Manna, P. K., et al.. (2024). Low temperature Raman spectroscopic study of anharmonic and spin-phonon coupled quasi-two dimensional rare earth based francisites. Journal of Physics Condensed Matter. 36(21). 215704–215704.
9.
Mohanta, Guru, et al.. (2014). STUDY ON AVAILABILITY AND AFFORDABILITY OF ANTI HYPERTENSIVE MEDICINES IN THE STATE OF KERALA. International Journal of Pharmacy and Pharmaceutical Sciences. 6(10). 364–369. 1 indexed citations
10.
Manna, P. K., et al.. (2011). Antioxidant Activity of Polyherbal Formulation on Streptozotocin Induced Diabetes in Experimental Animals. HAL (Le Centre pour la Communication Scientifique Directe). 6 indexed citations
11.
Prasad, Tulika, et al.. (2011). AN OVERVIEW OF STATINS AS HYPOLIPIDEMIC DRUGS. International Journal of Pharmaceutical Sciences and Drug Research. 178–183. 18 indexed citations
12.
Manna, P. K., et al.. (2010). Emerging trends in medicine procurement in government sector in India - A critical study. 1(3). 372–381. 4 indexed citations
13.
Panda, Amulya K., et al.. (2010). Design,in vitroandin vivoevaluation of glipizide Eudragit microparticles. Journal of Microencapsulation. 27(4). 281–291. 14 indexed citations
14.
Sivakumar, Thanapal, et al.. (2007). DESIGN AND EVALUATION OF DICLOFENAC SODIUM MEGALOPOROUS MATRIX SYSTEM AIMED FOR COLONIC DRUG DELIVERY. Iranian journal of pharmaceutical sciences. 3(1). 1–12. 1 indexed citations
15.
Kalaiselvan, R, et al.. (2007). Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques.. PubMed. 62(8). 604–7. 16 indexed citations
16.
Mohanta, Guru, et al.. (2004). Studies on Hepatoprotective Effect of Flaveria trinervia. Journal of Natural Remedies. 4(2). 168–173. 3 indexed citations
17.
Mohanta, Guru, et al.. (2003). Antibacterial and Antifungal Activity of Andrographis echiodes. Journal of Natural Remedies. 3(2). 185–188. 17 indexed citations
18.
Mohanta, Guru, P. K. Manna, & R. Manavalan. (2002). Physicochemical and biological evaluation of erythromycin nicotinate, a new derivative of erythromycin. Indian Journal of Pharmaceutical Sciences. 64(5). 489–491. 3 indexed citations
19.
Manna, P. K., et al.. (1999). Studies of Erythromycin Maltobionate, a New Derivative of Erythromycin. Drug Development and Industrial Pharmacy. 25(3). 391–395. 3 indexed citations
20.
Manna, P. K., et al.. (1999). Lathyrus and Lathyrism: A review. International Journal of Food Properties. 2(3). 197–203. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026